ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.05 -0.27 (-6.25%)
As of: Oct 23, 2026 · 2:09 PM EDT

ARS Pharmaceuticals (SPRY) Net Preferred Shares Issued and Repurchased (2020 - 2021)

Updated

Analysis

ARS Pharmaceuticals (SPRY) Net Preferred Shares Issued and Repurchased (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,126.20 Bn 1,094.78 Bn 19.71 Bn -
2 Johnson & Johnson 633.36 Bn 553.22 Bn 17.30 Bn -
3 AbbVie 504.51 Bn 477.62 Bn 12.70 Bn -
4 Merck 357.58 Bn 311.96 Bn 12.21 Bn -
5 Novartis Ag 289.65 Bn 253.64 Bn 11.24 Bn -
6 Astrazeneca 264.97 Bn 238.66 Bn 12.86 Bn -
7 Amgen 237.69 Bn 193.09 Bn 7.24 Bn -
8 Gilead Sciences 194.48 Bn 168.68 Bn 6.22 Bn -
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 ARS Pharmaceuticals 402.22 Mn 258.42 Mn 20.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 54.81 Mn
Dec 31, 2020 -50,000.00
Sep 30, 2020 119.69 Mn
Jun 30, 2020 12.05 Mn
Mar 31, 2020 21.66 Mn
API Access

ARS Pharmaceuticals Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=SPRY&period=max&api_key=YOUR_API_KEY